Cargando…
High expression of MCM10 is predictive of poor outcomes in lung adenocarcinoma
BACKGROUNDS: Lung adenocarcinoma is a complex disease that results in over 1.8 million deaths a year. Recent advancements in treating and managing lung adenocarcinoma have led to modest decreases in associated mortality rates, owing in part to the multifactorial etiology of the disease. Novel progno...
Autores principales: | Shao, Mingrui, Yang, Shize, Dong, Siyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866887/ https://www.ncbi.nlm.nih.gov/pubmed/33604163 http://dx.doi.org/10.7717/peerj.10560 |
Ejemplares similares
-
CKS2 and RMI2 are two prognostic biomarkers of lung adenocarcinoma
por: Xiao, Dayong, et al.
Publicado: (2020) -
High expression of PIMREG predicts poor survival outcomes and is correlated with immune infiltrates in lung adenocarcinoma
por: Jiang, Feng, et al.
Publicado: (2021) -
Expression of collagen type 1 alpha 1 indicates lymph node metastasis and poor outcomes in squamous cell carcinomas of the lung
por: Dong, Siyuan, et al.
Publicado: (2020) -
Upregulated expression of pyruvate kinase M2 mRNA predicts poor prognosis in lung adenocarcinoma
por: Wang, Guiping, et al.
Publicado: (2020) -
CMTM6 is highly expressed in lung adenocarcinoma and can be used as a biomarker of a poor diagnosis
por: Jia, Daqi, et al.
Publicado: (2023)